HEADER OXIDOREDUCTASE(OXYGEN RECEPTOR) 14-JUN-93 1COY TITLE CRYSTAL STRUCTURE OF CHOLESTEROL OXIDASE COMPLEXED WITH A STEROID TITLE 2 SUBSTRATE. IMPLICATIONS FOR FAD DEPENDENT ALCOHOL OXIDASES COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLESTEROL OXIDASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.3.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BREVIBACTERIUM STEROLICUM; SOURCE 3 ORGANISM_TAXID: 1702 KEYWDS OXIDOREDUCTASE(OXYGEN RECEPTOR) EXPDTA X-RAY DIFFRACTION AUTHOR J.LI,A.VRIELINK,P.BRICK,D.M.BLOW REVDAT 4 07-FEB-24 1COY 1 REMARK SEQADV REVDAT 3 29-NOV-17 1COY 1 HELIX REVDAT 2 24-FEB-09 1COY 1 VERSN REVDAT 1 31-OCT-93 1COY 0 JRNL AUTH J.LI,A.VRIELINK,P.BRICK,D.M.BLOW JRNL TITL CRYSTAL STRUCTURE OF CHOLESTEROL OXIDASE COMPLEXED WITH A JRNL TITL 2 STEROID SUBSTRATE: IMPLICATIONS FOR FLAVIN ADENINE JRNL TITL 3 DINUCLEOTIDE DEPENDENT ALCOHOL OXIDASES. JRNL REF BIOCHEMISTRY V. 32 11507 1993 JRNL REFN ISSN 0006-2960 JRNL PMID 8218217 JRNL DOI 10.1021/BI00094A006 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.VRIELINK,L.F.LLOYD,D.M.BLOW REMARK 1 TITL CRYSTAL STRUCTURE OF CHOLESTEROL OXIDASE FROM BREVIBACTERIUM REMARK 1 TITL 2 STEROLICUM REFINED AT 1.8 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 219 533 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.OHTA,K.FUJISHIRO,K.YAMAGUCHI,Y.TAMURA,K.AISAKA,T.UWAJIMA, REMARK 1 AUTH 2 M.HASEGAWA REMARK 1 TITL SEQUENCE OF GENE CHOB ENCODING CHOLESTEROL OXIDASE OF REMARK 1 TITL 2 BREVIBACTERIUM STEROLICUM: COMPARISON WITH CHOA OF REMARK 1 TITL 3 STREPTOMYCES SP. SA-COO REMARK 1 REF GENE V. 103 93 1991 REMARK 1 REFN ISSN 0378-1119 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3771 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 424 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.350 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1COY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172445. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.96500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.96500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.11500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.96500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.96500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.11500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 PRO A 2 REMARK 465 SER A 3 REMARK 465 GLY A 434 REMARK 465 VAL A 435 REMARK 465 GLN A 507 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 4 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 11 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 54 CE NZ REMARK 470 LEU A 60 CG CD1 CD2 REMARK 470 ASN A 61 CG OD1 ND2 REMARK 470 LYS A 64 NZ REMARK 470 ASP A 71 OD1 OD2 REMARK 470 LYS A 72 CD CE NZ REMARK 470 GLN A 75 CG CD OE1 NE2 REMARK 470 SER A 78 OG REMARK 470 ILE A 85 CG1 CG2 CD1 REMARK 470 ARG A 91 NH2 REMARK 470 LYS A 381 NZ REMARK 470 ARG A 387 CZ NH1 NH2 REMARK 470 LYS A 396 CE NZ REMARK 470 LYS A 415 CE NZ REMARK 470 GLN A 422 CD OE1 NE2 REMARK 470 TYR A 436 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 456 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 146 -57.51 -136.14 REMARK 500 SER A 211 -70.38 -131.16 REMARK 500 VAL A 217 -61.93 -168.29 REMARK 500 THR A 231 -95.30 -115.36 REMARK 500 SER A 259 159.33 171.75 REMARK 500 ALA A 288 36.09 -140.28 REMARK 500 ASP A 334 57.74 -117.01 REMARK 500 ALA A 356 64.22 -151.79 REMARK 500 LYS A 456 -65.51 -125.95 REMARK 500 ASP A 459 -166.87 -78.81 REMARK 500 ASP A 474 -161.73 -123.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE STRUCTURE CONTAINS AN FAD COFACTOR IN THE REDUCED FORM. REMARK 600 THE FLAVIN RING SYSTEM OF THE FAD MOLECULE ADOPTS A REMARK 600 SLIGHTLY TWISTED CONFORMATION. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AND A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 510 DBREF 1COY A 1 507 UNP P22637 CHOD_BREST 46 552 SEQADV 1COY TYR A 437 UNP P22637 PHE 482 CONFLICT SEQADV 1COY ALA A 492 UNP P22637 ARG 537 CONFLICT SEQRES 1 A 507 ALA PRO SER ARG THR LEU ALA ASP GLY ASP ARG VAL PRO SEQRES 2 A 507 ALA LEU VAL ILE GLY SER GLY TYR GLY GLY ALA VAL ALA SEQRES 3 A 507 ALA LEU ARG LEU THR GLN ALA GLY ILE PRO THR GLN ILE SEQRES 4 A 507 VAL GLU MET GLY ARG SER TRP ASP THR PRO GLY SER ASP SEQRES 5 A 507 GLY LYS ILE PHE CYS GLY MET LEU ASN PRO ASP LYS ARG SEQRES 6 A 507 SER MET TRP LEU ALA ASP LYS THR ASP GLN PRO VAL SER SEQRES 7 A 507 ASN PHE MET GLY PHE GLY ILE ASN LYS SER ILE ASP ARG SEQRES 8 A 507 TYR VAL GLY VAL LEU ASP SER GLU ARG PHE SER GLY ILE SEQRES 9 A 507 LYS VAL TYR GLN GLY ARG GLY VAL GLY GLY GLY SER LEU SEQRES 10 A 507 VAL ASN GLY GLY MET ALA VAL THR PRO LYS ARG ASN TYR SEQRES 11 A 507 PHE GLU GLU ILE LEU PRO SER VAL ASP SER ASN GLU MET SEQRES 12 A 507 TYR ASN LYS TYR PHE PRO ARG ALA ASN THR GLY LEU GLY SEQRES 13 A 507 VAL ASN ASN ILE ASP GLN ALA TRP PHE GLU SER THR GLU SEQRES 14 A 507 TRP TYR LYS PHE ALA ARG THR GLY ARG LYS THR ALA GLN SEQRES 15 A 507 ARG SER GLY PHE THR THR ALA PHE VAL PRO ASN VAL TYR SEQRES 16 A 507 ASP PHE GLU TYR MET LYS LYS GLU ALA ALA GLY GLN VAL SEQRES 17 A 507 THR LYS SER GLY LEU GLY GLY GLU VAL ILE TYR GLY ASN SEQRES 18 A 507 ASN ALA GLY LYS LYS SER LEU ASP LYS THR TYR LEU ALA SEQRES 19 A 507 GLN ALA ALA ALA THR GLY LYS LEU THR ILE THR THR LEU SEQRES 20 A 507 HIS ARG VAL THR LYS VAL ALA PRO ALA THR GLY SER GLY SEQRES 21 A 507 TYR SER VAL THR MET GLU GLN ILE ASP GLU GLN GLY ASN SEQRES 22 A 507 VAL VAL ALA THR LYS VAL VAL THR ALA ASP ARG VAL PHE SEQRES 23 A 507 PHE ALA ALA GLY SER VAL GLY THR SER LYS LEU LEU VAL SEQRES 24 A 507 SER MET LYS ALA GLN GLY HIS LEU PRO ASN LEU SER SER SEQRES 25 A 507 GLN VAL GLY GLU GLY TRP GLY ASN ASN GLY ASN ILE MET SEQRES 26 A 507 VAL GLY ARG ALA ASN HIS MET TRP ASP ALA THR GLY SER SEQRES 27 A 507 LYS GLN ALA THR ILE PRO THR MET GLY ILE ASP ASN TRP SEQRES 28 A 507 ALA ASP PRO THR ALA PRO ILE PHE ALA GLU ILE ALA PRO SEQRES 29 A 507 LEU PRO ALA GLY LEU GLU THR TYR VAL SER LEU TYR LEU SEQRES 30 A 507 ALA ILE THR LYS ASN PRO GLU ARG ALA ARG PHE GLN PHE SEQRES 31 A 507 ASN SER GLY THR GLY LYS VAL ASP LEU THR TRP ALA GLN SEQRES 32 A 507 SER GLN ASN GLN LYS GLY ILE ASP MET ALA LYS LYS VAL SEQRES 33 A 507 PHE ASP LYS ILE ASN GLN LYS GLU GLY THR ILE TYR ARG SEQRES 34 A 507 THR ASP LEU PHE GLY VAL TYR TYR LYS THR TRP GLY ASP SEQRES 35 A 507 ASP PHE THR TYR HIS PRO LEU GLY GLY VAL LEU LEU ASN SEQRES 36 A 507 LYS ALA THR ASP ASN PHE GLY ARG LEU PRO GLU TYR PRO SEQRES 37 A 507 GLY LEU TYR VAL VAL ASP GLY SER LEU VAL PRO GLY ASN SEQRES 38 A 507 VAL GLY VAL ASN PRO PHE VAL THR ILE THR ALA LEU ALA SEQRES 39 A 507 GLU ARG ASN MET ASP LYS ILE ILE SER SER ASP ILE GLN HET AND A 508 21 HET FAD A 510 53 HETNAM AND 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE FORMUL 2 AND C19 H28 O2 FORMUL 3 FAD C27 H33 N9 O15 P2 FORMUL 4 HOH *424(H2 O) HELIX 1 H1 TYR A 21 GLN A 32 1 12 HELIX 2 H2 ARG A 128 ILE A 134 1 7 HELIX 3 H3A SER A 140 ASN A 145 1 6 HELIX 4 H3B TYR A 147 LEU A 155 1 9 HELIX 5 H4 GLN A 162 SER A 167 1 6 HELIX 6 H5A GLU A 169 TYR A 171 5 3 HELIX 7 H5B LYS A 172 ARG A 183 1 12 HELIX 8 H6 PHE A 197 ALA A 204 1 8 HELIX 9 H7A LEU A 228 LYS A 230 5 3 HELIX 10 H7B TYR A 232 ALA A 238 1 7 HELIX 11 H8 GLY A 290 ALA A 303 1 14 HELIX 12 H9A GLN A 403 ASN A 406 5 4 HELIX 13 H9B GLN A 407 GLU A 424 1 18 HELIX 14 H10 PHE A 487 SER A 504 1 18 SHEET 1 A 6 LEU A 242 THR A 245 0 SHEET 2 A 6 THR A 37 VAL A 40 1 O THR A 37 N THR A 243 SHEET 3 A 6 ALA A 14 ILE A 17 1 O ALA A 14 N GLN A 38 SHEET 4 A 6 ARG A 284 PHE A 287 1 O ARG A 284 N LEU A 15 SHEET 5 A 6 LEU A 470 VAL A 472 1 O TYR A 471 N PHE A 287 SHEET 6 A 6 ARG A 463 PRO A 465 -1 N LEU A 464 O LEU A 470 SHEET 1 B 6 THR A 188 PHE A 190 0 SHEET 2 B 6 MET A 346 ASP A 349 -1 N GLY A 347 O ALA A 189 SHEET 3 B 6 ILE A 358 ILE A 362 -1 N ALA A 360 O ILE A 348 SHEET 4 B 6 VAL A 373 THR A 380 -1 N ILE A 379 O PHE A 359 SHEET 5 B 6 ILE A 324 ALA A 329 -1 N VAL A 326 O TYR A 376 SHEET 6 B 6 THR A 439 GLY A 441 -1 N GLY A 441 O MET A 325 SHEET 1 C 4 ARG A 11 VAL A 12 0 SHEET 2 C 4 VAL A 274 ALA A 282 1 O THR A 281 N VAL A 12 SHEET 3 C 4 TYR A 261 ILE A 268 -1 O TYR A 261 N ALA A 282 SHEET 4 C 4 HIS A 248 PRO A 255 -1 N ARG A 249 O GLU A 266 SHEET 1 D 3 LEU A 96 ARG A 100 0 SHEET 2 D 3 LYS A 105 GLY A 109 -1 O GLN A 108 N ASP A 97 SHEET 3 D 3 PHE A 444 THR A 445 1 N THR A 445 O LYS A 105 SHEET 1 E 2 TRP A 318 GLY A 319 0 SHEET 2 E 2 PRO A 448 LEU A 449 -1 O LEU A 449 N GLY A 319 SHEET 1 F 2 PHE A 388 ASN A 391 0 SHEET 2 F 2 LYS A 396 LEU A 399 -1 N ASP A 398 O GLN A 389 SITE 1 AC1 10 GLN A 75 VAL A 77 PHE A 83 GLY A 120 SITE 2 AC1 10 THR A 342 PRO A 344 ALA A 363 LEU A 375 SITE 3 AC1 10 TYR A 446 FAD A 510 SITE 1 AC2 38 GLY A 18 GLY A 20 TYR A 21 GLY A 22 SITE 2 AC2 38 GLU A 41 MET A 42 TYR A 107 GLY A 109 SITE 3 AC2 38 ARG A 110 GLY A 111 GLY A 114 GLY A 115 SITE 4 AC2 38 VAL A 118 ASN A 119 GLY A 120 GLY A 121 SITE 5 AC2 38 MET A 122 HIS A 248 VAL A 250 ALA A 288 SITE 6 AC2 38 ALA A 289 GLY A 290 TYR A 446 HIS A 447 SITE 7 AC2 38 ASP A 474 GLY A 475 ASN A 485 PRO A 486 SITE 8 AC2 38 PHE A 487 AND A 508 HOH A 517 HOH A 518 SITE 9 AC2 38 HOH A 524 HOH A 530 HOH A 533 HOH A 535 SITE 10 AC2 38 HOH A 573 HOH A 600 CRYST1 67.930 84.230 87.930 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014721 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011872 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011373 0.00000